AKT in cancer: new molecular insights and advances in drug developmentPrabhjot S. Mundi, Kevin Kalinsky, Carolyn K. McCourt et al.|British Journal of Clinical Pharmacology|2016Cited by 267
Effect of Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated TumorKevin Kalinsky, Keith T. Flaherty, Fangxin Hong et al.|JAMA Oncology|2020Cited by 106